104 related articles for article (PubMed ID: 14574629)
21. Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives.
Wang YJ; Zhou HD; Zhou XF
Drug Discov Today; 2006 Oct; 11(19-20):931-8. PubMed ID: 16997144
[TBL] [Abstract][Full Text] [Related]
22. Independent effects of APOE on cholesterol metabolism and brain Abeta levels in an Alzheimer disease mouse model.
Mann KM; Thorngate FE; Katoh-Fukui Y; Hamanaka H; Williams DL; Fujita S; Lamb BT
Hum Mol Genet; 2004 Sep; 13(17):1959-68. PubMed ID: 15229191
[TBL] [Abstract][Full Text] [Related]
23. Reciprocal regulation of cholesterol and beta amyloid at the subcellular level in Alzheimer's disease.
Posse de Chaves E
Can J Physiol Pharmacol; 2012 Jun; 90(6):753-64. PubMed ID: 22626060
[TBL] [Abstract][Full Text] [Related]
24. Analysis of Abeta interactions using ProteinChip technology.
Giannakis E; Hung LW; Camacaro KP; Smith DP; Barnham KJ; Wade JD
Methods Mol Biol; 2008; 494():71-86. PubMed ID: 18726569
[TBL] [Abstract][Full Text] [Related]
25. Amyloid excess in Alzheimer's disease: what is cholesterol to be blamed for?
Ledesma MD; Dotti CG
FEBS Lett; 2006 Oct; 580(23):5525-32. PubMed ID: 16814780
[TBL] [Abstract][Full Text] [Related]
26. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.
Barghorn S; Nimmrich V; Striebinger A; Krantz C; Keller P; Janson B; Bahr M; Schmidt M; Bitner RS; Harlan J; Barlow E; Ebert U; Hillen H
J Neurochem; 2005 Nov; 95(3):834-47. PubMed ID: 16135089
[TBL] [Abstract][Full Text] [Related]
27. Identification and characterisation of the novel amyloid-beta peptide-induced protein p17.
Nehar S; Mishra M; Heese K
FEBS Lett; 2009 Oct; 583(19):3247-53. PubMed ID: 19755123
[TBL] [Abstract][Full Text] [Related]
28. Amyloid beta as a regulator of lipid homeostasis.
Grimm MO; Grimm HS; Hartmann T
Trends Mol Med; 2007 Aug; 13(8):337-44. PubMed ID: 17644432
[TBL] [Abstract][Full Text] [Related]
29. Cholesterol depletion reduces aggregation of amyloid-beta peptide in hippocampal neurons.
Schneider A; Schulz-Schaeffer W; Hartmann T; Schulz JB; Simons M
Neurobiol Dis; 2006 Sep; 23(3):573-7. PubMed ID: 16777421
[TBL] [Abstract][Full Text] [Related]
30. Cysteine proteases are the major beta-secretase in the regulated secretory pathway that provides most of the beta-amyloid in Alzheimer's disease: role of BACE 1 in the constitutive secretory pathway.
Hook VY; Reisine TD
J Neurosci Res; 2003 Nov; 74(3):393-405. PubMed ID: 14598316
[TBL] [Abstract][Full Text] [Related]
31. Cell biology: infectious Alzheimer's disease?
Riek R
Nature; 2006 Nov; 444(7118):429-31. PubMed ID: 17122841
[No Abstract] [Full Text] [Related]
32. Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity.
Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; de Waal RM; Verbeek MM
Brain Res; 2006 May; 1089(1):67-78. PubMed ID: 16635482
[TBL] [Abstract][Full Text] [Related]
33. Alzheimer amyloid-beta peptides block the activation of C/EBPbeta and C/EBPdelta in glial cells.
Samuelsson M; Ramberg V; Iverfeldt K
Biochem Biophys Res Commun; 2008 Jun; 370(4):619-22. PubMed ID: 18405661
[TBL] [Abstract][Full Text] [Related]
34. [Oxidative stress, beta-amyloide peptide and Alzheimer's disease].
Manzano-León N; Mas-Oliva J
Gac Med Mex; 2006; 142(3):229-38. PubMed ID: 16875352
[TBL] [Abstract][Full Text] [Related]
35. Requirement of aggregation propensity of Alzheimer amyloid peptides for neuronal cell surface binding.
Bateman DA; McLaurin J; Chakrabartty A
BMC Neurosci; 2007 May; 8():29. PubMed ID: 17475015
[TBL] [Abstract][Full Text] [Related]
36. Possible causes of Alzheimer's disease: amyloid fragments, free radicals, and calcium homeostasis.
Hölscher C
Neurobiol Dis; 1998 Sep; 5(3):129-41. PubMed ID: 9848086
[TBL] [Abstract][Full Text] [Related]
37. Genetic association of acyl-coenzyme A: cholesterol acyltransferase with cerebrospinal fluid cholesterol levels, brain amyloid load, and risk for Alzheimer's disease.
Wollmer MA; Streffer JR; Tsolaki M; Grimaldi LM; Lütjohann D; Thal D; von Bergmann K; Nitsch RM; Hock C; Papassotiropoulos A
Mol Psychiatry; 2003 Jun; 8(6):635-8. PubMed ID: 12851640
[TBL] [Abstract][Full Text] [Related]
38. Abeta(25-35) as proxyholder for amyloidogenic peptides: in vivo evidence.
Gulyaeva NV; Stepanichev MY
Exp Neurol; 2010 Mar; 222(1):6-9. PubMed ID: 20043907
[No Abstract] [Full Text] [Related]
39. Mechanism of cholesterol-assisted oligomeric channel formation by a short Alzheimer β-amyloid peptide.
Di Scala C; Troadec JD; Lelièvre C; Garmy N; Fantini J; Chahinian H
J Neurochem; 2014 Jan; 128(1):186-95. PubMed ID: 23919567
[TBL] [Abstract][Full Text] [Related]
40. Inflammation, antichymotrypsin, and lipid metabolism: autogenic etiology of Alzheimer's disease.
Janciauskiene S; Wright HT
Bioessays; 1998 Dec; 20(12):1039-46. PubMed ID: 10048303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
